| Disease control priorities in developing countries JH Bryant, PF Harrison Global Health in Transition: A Synthesis: Perspectives from International …, 1996 | 790 | 1996 |
| Health and economic benefits of public financing of epilepsy treatment in India: An agent‐based simulation model I Megiddo, A Colson, D Chisholm, T Dua, A Nandi, R Laxminarayan Epilepsia 57 (3), 464-474, 2016 | 270 | 2016 |
| COVID-19 vaccination in lower-middle income countries: national stakeholder views on challenges, barriers, and potential solutions ET Tagoe, N Sheikh, A Morton, J Nonvignon, AR Sarker, L Williams, ... Frontiers in Public Health 9, 709127, 2021 | 104 | 2021 |
| Reduced burden of childhood diarrheal diseases through increased access to water and sanitation in India: A modeling analysis A Nandi, I Megiddo, A Ashok, A Verma, R Laxminarayan Social Science & Medicine 180, 181-192, 2017 | 80 | 2017 |
| Analysis of the Universal Immunization Programme and introduction of a rotavirus vaccine in India with IndiaSim I Megiddo, AR Colson, A Nandi, S Chatterjee, S Prinja, A Khera, ... Vaccine 32, A151-A161, 2014 | 47 | 2014 |
| Evaluating intervention strategies in controlling coronavirus disease 2019 (COVID-19) spread in care homes: An agent-based model S Howick, D McLafferty, GH Anderson, SJ Pravinkumar, R Van Der Meer, ... Infection Control & Hospital Epidemiology 42 (9), 1060-1070, 2021 | 40 | 2021 |
| Universal health coverage for mental, neurological, and substance use disorders: an extended cost-effectiveness analysis D Chisholm, KA Johansson, N Raykar, I Megiddo, A Nigam, KB Strand, ... Mental, neurological, and substance use disorders, 237, 2016 | 26 | 2016 |
| Simulation models for transmission of health care–associated infection: A systematic review I Megiddo, S Howick American journal of infection control 48 (7), 810-821, 2020 | 24 | 2020 |
| Antimicrobial resistance: is health technology assessment part of the solution or part of the problem? AR Colson, A Morton, C Ĺrdal, K Chalkidou, SC Davies, LP Garrison, M Jit, ... Value in Health 24 (12), 1828-1834, 2021 | 22 | 2021 |
| Cost-effectiveness of treatment and secondary prevention of acute myocardial infarction in India: a modeling study I Megiddo, S Chatterjee, A Nandi, R Laxminarayan Global heart 9 (4), 391-398. e3, 2014 | 22 | 2014 |
| Quantifying uncertainty about future antimicrobial resistance: Comparing structured expert judgment and statistical forecasting methods AR Colson, I Megiddo, G Alvarez-Uria, S Gandra, T Bedford, A Morton, ... PloS one 14 (7), e0219190, 2019 | 21 | 2019 |
| Economic and epidemiological impact of dengue illness over 16 years from a public health system perspective in Brazil to inform future health policies including the adoption of … IP Godói, LVD Da Silva, AR Sarker, I Megiddo, A Morton, B Godman, ... Expert review of vaccines 17 (12), 1123-1133, 2018 | 21 | 2018 |
| Economic and epidemiological impact of dengue illness over 16 years from a public health system perspective in Brazil to inform future health policies including the adoption of … IP Godói, LVD Da Silva, AR Sarker, I Megiddo, A Morton, B Godman, ... Expert review of vaccines 17 (12), 1123-1133, 2018 | 21 | 2018 |
| Health and economic benefits of scaling up a home-based neonatal care package in rural India: a modelling analysis A Nandi, AR Colson, A Verma, I Megiddo, A Ashok, R Laxminarayan Health policy and planning 31 (5), 634-644, 2016 | 21 | 2016 |
| Self-enforcing regional vaccination agreements P Klepac, I Megiddo, BT Grenfell, R Laxminarayan Journal of The Royal Society Interface 13 (114), 20150907, 2016 | 17 | 2016 |
| Potential impact of introducing the pneumococcal conjugate vaccine into national immunisation programmes: an economic-epidemiological analysis using data from India I Megiddo, E Klein, R Laxminarayan BMJ global health 3 (3), e000636, 2018 | 15 | 2018 |
| Impact of visitation and cohorting policies to shield residents from covid-19 spread in care homes: an agent-based model S Howick, D McLafferty, GH Anderson, SJ Pravinkumar, R Van Der Meer, ... American Journal of Infection Control 49 (9), 1105-1112, 2021 | 14 | 2021 |
| Investing in antibiotics to alleviate future catastrophic outcomes: What is the value of having an effective antibiotic to mitigate pandemic influenza? I Megiddo, D Drabik, T Bedford, A Morton, J Wesseler, R Laxminarayan Health Economics 28 (4), 556-571, 2019 | 14 | 2019 |
| COVID‑19 vaccination in Lower‑Middle Income Countries: National Stake‑holder views on Challenges, Barriers, and potential solutions. Front Public Health. 2021; 9: 709127 ET Tagoe, N Sheikh, A Morton, J Nonvignon, AR Sarker, L Williams, ... PubMed, 2021 | 12 | 2021 |
| Mind the costs, too: towards better cost-effectiveness analyses of PBF programmes YL Chi, M Gad, S Bauhoff, K Chalkidou, I Megiddo, F Ruiz, P Smith BMJ Global Health 3 (5), e000994, 2018 | 10 | 2018 |
